Most of my research is geared toward treating progressive forms of MS. The reason why I like desipramine so well, is that it overlaps and shows evidence of efficacy on the very same individual physiological processes as minocycline, LDN, and the interferons. Broader spectrum of action in one pill, as they say.
I will post my most recent compilation of data that I found on the other thread regarding desipramine (not to push the drug, but just because all of the data will then be located in one place, if anyone is interested.)
Again........since I myself have a progressive form of MS, my concentration is on preventing and reversing axonal damage, not just remyelination alone.
Thanks for your interest.
P.S. I do still plan on discussing these findings with the Sriram team, as my next appointment is with them.